This Solicitation opportunity from Department Of Health And Human Services was posted on August 7, 2026. The submission period has ended. Browse the details below for market research, or find similar active opportunities.

Top

Library of Pharmacologically Active Compounds (LOP

Awarded

75N98026Q00991Federal

Submission Closed08/24/2026, 12:00:00 PM UTC

Contract Overview

Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.

Active Opportunities Like This One

NAICS: 325412

New

DIBBS

Supply of Electrical Insulation Tape (NSN 5970-01-012-4280)This subcontract involves the supply of electrical insulation tape, identified by NSN 5970-01-012-4280, for prime contractors working on DLA Weapons Support ASC projects. The contractor is required to provide two rolls of tape delivered FOB Origin to Evenes Airbase. All materials must strictly conform to technical specification BASIC CID A-A-59474D, Revision D, and adhere to MIL-STD-2073-1E and RP001 for packaging and MIL-STD-129 for marking. To be eligible, the supplier must hold either SAE AS9003 or ISO 9001 certification and maintain full compliance with DFARS 252.204-7012. This procurement is managed by the Department of Defense under the DLA Weapons Support ASC Supplier Oper AE and AF Div, with a response deadline set for November 5, 2026.

DLA WEAPONS SUPPORT ASC SUPPLIER OPER AE AND AF DIV

POSTED

DEADLINE

Sterile X-Ray Detectable Packing Gauze SupplierThis subcontract involves the supply of 640 units of sterile, medical-grade packing gauze for prime contractors supporting Department of Defense medical supply contracts. The required product is a 1-ply, soft, white Z-fold gauze measuring 3 inches by 5 yards, featuring an embedded X-ray detectable line. To ensure clinical safety and longevity, the gauze must be sterilized to medical standards to maintain a shelf life of 60 months. The contract is managed under the Medical Supply Chain MD Surg FSF and requires strict adherence to the Berry Amendment and the Buy American Act for NSN 6510-01-695-5824. Performance for this requirement is centered in San Diego, California. Interested parties must note the response deadline of November 3, 2026.

MEDICAL SUPPLY CHAIN MD SURG FSF

POSTED

DEADLINE

Supply of Tolnaftate Powder (USP 1%)This subcontract involves the supply of Tolnaftate Powder, USP 1%, to prime contractors supporting the Department of Defense Medical Supply Chain Pharm FSA. The requirement specifies the delivery of two bottles of pharmaceutical product, with each unit consisting of a 45 GM sealed container. All supplies must strictly adhere to United States Pharmacopeia standards and utilize commercial packaging and packing methods to ensure the integrity of the contents. The opportunity is categorized under NAICS code 325412 and is associated with a performance location in FPO 96678. Interested parties must note the response deadline of November 3, 2026, following the posting date of October 28, 2026.

MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

DEADLINE

Supplier of Disposable PVP Iodine ApplicatorsThis subcontract involves the supply of individually packaged disposable PVP Iodine swab sticks to prime contractors supporting Department of Defense medical supply contracts through DLA Troop Support. The required product must match NSN 6515-01-519-2226, utilizing medical-grade Povidone-Iodine solution and medical-grade packaging. Each delivery unit consists of packages containing 50 applicators. Strict quality and timing standards are mandated, requiring a minimum shelf life of 15 months and delivery within two months of the date of manufacture. The contract is categorized under NAICS code 325412 and is managed by the Medical Supply Chain MD Surg FSF. Performance for this requirement is designated for FPO 09592-4700.

MEDICAL SUPPLY CHAIN MD SURG FSF

POSTED

DEADLINE

Supply of Calcium Carbonate Chewable TabletsThis subcontract involves the supply of regular strength, peppermint-flavored calcium carbonate chewable tablets for prime contractors supporting the Department of Defense via the Medical Supply Chain Pharm FSA. The requirement specifies 500 MG tablets provided in bottles of 150 count, with a total delivery of 10 bottles. All products must adhere to a non-extendable shelf life of 36 months under Type I, Code Q specifications. The provider must maintain pharmaceutical manufacturing qualifications and ensure full FDA compliance for over-the-counter medications. Performance for this contract is designated for Fort Stewart, Georgia. Interested parties must respond by November 3, 2026, in accordance with the solicitation guidelines.

MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

DEADLINE

Lidocaine Hydrochloride and Dextrose Injection ManufacturerThis subcontract involves the manufacture and supply of sterile, nonpyrogenic Lidocaine Hydrochloride and Dextrose Injection to support prime contractors fulfilling Department of Defense supply contracts through the Medical Supply Chain Pharm FSA. The production process requires compounding 2g of Lidocaine Hydrochloride USP and 5g of Hydrous Dextrose USP with Water for Injection USP to achieve a 500 ML bag fill volume. All manufacturing must occur in sterile compounding environments using containers that are latex-free, DEHP-free, and PVC-free to ensure full compliance with USP standards and FDA requirements. The performance of this contract is based in Williamsburg, Virginia, under NAICS code 325412. The scope of work concludes with the delivery of finished sterile injection bags. Interested parties should note the response deadline of November 3, 2026, for this specific procurement opportunity.

MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

DEADLINE

Supply of Chlorine Dioxide Water Purification TabletsThis subcontract involves the supply of stabilized chlorine dioxide water purification tablets for prime contractors supporting Department of Defense projects under the DLA Troop Support Medical Supply Chain. The required tablets must contain no active chlorine or iodine and be delivered in units of 10 individually sealed tablets per package. To ensure operational readiness, the product must maintain a 60-month shelf life and adhere strictly to Medical Marking Standard No. 1 and MIL-STD-2073-1E. The scope of work requires the delivery of 10 packages of tablets on a FOB Destination basis. The project is categorized under NAICS code 325412 and is managed by the Medical Supply Chain Pharm FSA. Performance for this contract is designated for APO 96319-5024.

MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

DEADLINE

Supply of Electrical Insulation Tape (NSN 5970010124280)This subcontract involves the supply of electrical insulation tape to prime contractors supporting Defense Logistics Agency Weapons Support aviation supply contracts. The requirement is for two rolls of tape in 36-yard units that strictly adhere to NSN 5970010124280 specifications. The contractor must ensure rigorous quality control and logistics compliance, performing sampling according to MIL-STD-1916 or ASQ H1331 Table 1. Additionally, all materials must be packaged and marked in accordance with MIL-STD-2073-1E, RP001, and MIL-STD-129 standards. This opportunity falls under NAICS code 325412 and is managed by the Department of Defense.

Defense Logistics Agency

POSTED

DEADLINE

Supplier of Multi-Parameter Urine Test Strips and Color ChartsThis subcontract opportunity is for the supply of multi-parameter urine test strips and corresponding color charts to support prime contractors on DLA Troop Support Medical Supply Chain projects for the Department of Defense. The required medical-grade strips must be capable of analyzing bilirubin, blood, glucose, ketone, leukocytes, nitrite, pH, protein, specific gravity, and urobilinogen. All products must strictly adhere to Regulation 862.1340 Class II and Medical Marking Standard No. 1, and must be delivered in bottles of 100 strips with a minimum shelf life of 18 months. The procurement falls under NAICS code 325412 and is managed by the Medical Supply Chain MD SURG FSF. The place of performance is designated as FPO 09592-4700. Interested parties should note the posted date of October 28, 2026, with a response deadline set for November 3, 2026.

MEDICAL SUPPLY CHAIN MD SURG FSF

POSTED

DEADLINE

Salicylic Acid Plaster SupplierThis subcontract involves the manufacture and supply of Salicylic Acid Plasters for prime contractors serving the Department of Defense Medical Supply Chain. The required plasters must measure 5.08 cm by 7.62 cm, feature a flannel back, and consist of a composition of 40 percent salicylic acid and 60 percent base. Each order must be packaged in units of 25 and maintain a minimum shelf life of 24 months. The supplier is responsible for delivering items under NSN 6510011202643 while ensuring full compliance with MIL-STD-129 and DFARS 252.225-7001 standards. Performance for this contract is designated for FPO 09592-4700, with the procurement falling under NAICS code 325412.

MEDICAL SUPPLY CHAIN MD SURG FSF

POSTED

DEADLINE

Salicylic Acid Gel SupplierThis subcontract involves the supply of 17 percent concentration Salicylic Acid Gel in 7 gram tubes for prime contractors supporting Department of Defense projects under the DLA Troop Support Medical Supply Chain. The supplier is responsible for manufacturing or sourcing the gel to exact concentration specifications and ensuring all packaging meets MIL-STD-2073-1E and RP001 medical-grade tubing standards. Additionally, the provider must adhere to Medical Marking Standard No. 1 and maintain Medical Controlled Room Temperature throughout the transport process. The contract is categorized under NAICS code 325412 and requires the delivery of the finished pharmaceutical product FOB Destination. Performance for this requirement is centered at Fort George G Meade. Interested parties must note the response deadline of November 3, 2026, for this medical supply chain procurement.

MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

DEADLINE

Isopropyl Alcohol (99% Isopropanol) SupplierThis subcontract involves the sourcing and manufacture of medical-grade 99 percent Isopropyl Alcohol to support prime contractors for the Department of Defense Medical Supply Chain Pharm FSA. The supplier is responsible for ensuring that all isopropanol meets USP Over-the-Counter standards and is produced using USP grade chemical materials within compliant bottling facilities. Key deliverables include the provision of the alcohol in bottles along with Safety Data Sheets for approval by the contracting officer. The performance of this contract is centered in FPO 96672, with a response deadline set for November 3, 2026.

MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

about 12 hours ago

DEADLINE

in 6 days

AI Contract Overview

The National Institutes of Health, Office of the Director, Office of Acquisitions, is soliciting proposals under solicitation number 75N98026Q00991 for the Library of Pharmacologically Active Compounds (LOPAC), conducted as a commercial item acquisition under FAR Subpart 12.6. This is an unrestricted, full and open competition with no set-aside, targeting vendors capable of delivering a defined set of pharmacologically active compounds as 1000x stock solutions in 100% DMSO for use in a broad cancer cell line screening study via the PRISM platform. The contract is a Firm-Fixed-Price type, with an estimated value not to exceed the simplified acquisition threshold of $250,000, and the NAICS code 325412 applies with a small business size standard of 1,300 employees. All offerors must be actively registered in the System for Award Management with a valid Unique Entity Identifier and Taxpayer Identification Number, and must certify their business size status. Proposals must include pricing details, shipping and handling costs, delivery timeframe, F.O.B. destination, and product catalog numbers, submitted electronically to [email hidden] by 8:00 AM EST on August 24, 2026. Performance is required to begin on September 4, 2026, with an end date of December 3, 2026, and deliverables include cell line viability data, assay quality control metrics, univariate and multivariate feature correlation analyses, and all raw data generated from screening activities, to be submitted through the PRISM Portal approximately four months after the submission window closes. The government will provide the test compound and expects full compliance with the PRISM assay protocol using an 8-point, 3-fold dilution series in a 5-day Luminex-format assay. Packaging must meet commercial standards, with no military specifications or labeling requirements beyond shipment in 100% DMSO to NIH/NCATS at 9808 Medical Center Drive, Rockville, MD 20850. Invoices must be submitted electronically via the Invoicing Processing Platform (IPP). Evaluation will be based on price, technical capability, past performance, and delivery schedule, with award going to the offeror providing the best value to the government through a trade-off process, not necessarily the lowest price. All

General Info

NIH seeks firm-fixed-price proposals for LOP library by August 24, 2026, unrestricted, small business eligible, Bethesda, Maryland.

Agency

Department Of Health And Human Services → National Institutes Of Health Olao

Contract Value

$27,983.63

NAICS

325412 - Pharmaceutical Preparation Manufacturing

Place of Performance

MD, USA

Set-Aside

NONE

Awardee

SIGMA-ALDRICH, INC.

Award Issued Date

09/21/2026, 12:00:00 AM UTC

Documents

RFQ 75N98026Q00991 for Library of Pharmacologically Active Compounds

rfq

High

AI Contract Breakdown

Uniform Contract Format

Timeline

PhaseAwarded

PostedAug 7

Solicitation

AwardedSep 21

Contract was awarded

Submission Closed

08/24/2026, 12:00:00 PM UTC

Find active opportunities like this

Get full access to discover similar active contracts, track opportunities, and build proposals with AI assistance.

Organization & Contact Information

AgencyDepartment Of Health And Human Services → National Institutes Of Health Olao

Contacts1 person available

OfficeBETHESDA, MD, 20892, USA

Organization / AgencyDepartment Of Health And Human Services → National Institutes Of Health Olao

Office AddressBETHESDA, MD, 20892, USA

Contacts

Jaddua C Johnston

contact@example.gov

+1 (555) 000-0000

Full Description

(i) This is a combined synopsis/solicitation for commercial items prepared in accordance with FAR Subpart 12.6, as supplemented with additional information included in this notice. This announcement constitutes only solicitation; proposals are being requested, and a separate written solicitation will not be issued.

(ii) The solicitation number is 75N98026Q00991. This solicitation is issued as a competitive combined synopsis/solicitation for commercial products or commercial services. The Government intends to award a contract or purchase order resulting from this solicitation using full and open competition.

This acquisition is conducted under the authority of FAR 12.603, Streamlined Solicitation for Commercial Products or Commercial Services, and is not expected to exceed the simplified acquisition threshold (if applicable).

The National Institutes of Health (NIH), Office of the Director, Office of Acquisitions, seeks to award a (Firm-Fixed-Price) to the offeror responsible whose proposal represents the best value to the Government.

(iii) The solicitation document and incorporated provisions and clauses are those in effect through Federal Acquisition Circular effective August 7, 2026

(iv) The associated NAICS code is 325412 Pharmaceutical Preparation Manufacturing and the small business size standard is 1300 employees.

This requirement is unrestricted.